Fullerton Health Achieves Milestone for Growth with Majority Stake Investment from New Strategic Partner Far East Drug
Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced today that it has come into an agreement with Far East Drug (B.V.I.) Co. Ltd. (“Far East Drug” or "FED"), involving an investment in a majority stake in the business by Far East Drug.
April 30, 2024